CD4 and tuberculosis: Among those diagnosed with TB, 14 (63.6%) were females, 11 (50.0%) were children less than 15 years of age, 77.3% had baseline WHO clinical stage of II, 31.8% had a baseline CD4 greater than 500 cells/ml, 15 (68.2%) had been on ART for more than 36 months, 13 (59.1%) were on an AZT backbone regimen, 12 (54.5%) were on an Efavirenz-based anchor regimen, 18 (81.8%) had completed IPT.